Re: [OPSAWG] draft-ietf-opsawg-mud-tls YANG Doctor review

mohamed.boucadair@orange.com Mon, 17 October 2022 11:01 UTC

Return-Path: <mohamed.boucadair@orange.com>
X-Original-To: opsawg@ietfa.amsl.com
Delivered-To: opsawg@ietfa.amsl.com
Received: from localhost (localhost [127.0.0.1]) by ietfa.amsl.com (Postfix) with ESMTP id 84AB5C1524A8 for <opsawg@ietfa.amsl.com>; Mon, 17 Oct 2022 04:01:46 -0700 (PDT)
X-Virus-Scanned: amavisd-new at amsl.com
X-Spam-Flag: NO
X-Spam-Score: -2.806
X-Spam-Level:
X-Spam-Status: No, score=-2.806 tagged_above=-999 required=5 tests=[BAYES_00=-1.9, DKIM_SIGNED=0.1, DKIM_VALID=-0.1, DKIM_VALID_AU=-0.1, DKIM_VALID_EF=-0.1, HTML_MESSAGE=0.001, RCVD_IN_DNSWL_LOW=-0.7, RCVD_IN_MSPIKE_H2=-0.001, RCVD_IN_ZEN_BLOCKED_OPENDNS=0.001, SPF_HELO_NONE=0.001, SPF_PASS=-0.001, T_SCC_BODY_TEXT_LINE=-0.01, UNPARSEABLE_RELAY=0.001, URIBL_DBL_BLOCKED_OPENDNS=0.001, URIBL_ZEN_BLOCKED_OPENDNS=0.001] autolearn=ham autolearn_force=no
Authentication-Results: ietfa.amsl.com (amavisd-new); dkim=pass (2048-bit key) header.d=orange.com
Received: from mail.ietf.org ([50.223.129.194]) by localhost (ietfa.amsl.com [127.0.0.1]) (amavisd-new, port 10024) with ESMTP id KK8pSKma2U-P for <opsawg@ietfa.amsl.com>; Mon, 17 Oct 2022 04:01:42 -0700 (PDT)
Received: from relais-inet.orange.com (relais-inet.orange.com [80.12.66.39]) (using TLSv1.3 with cipher TLS_AES_256_GCM_SHA384 (256/256 bits) key-exchange X25519 server-signature RSA-PSS (2048 bits) server-digest SHA256) (No client certificate requested) by ietfa.amsl.com (Postfix) with ESMTPS id A6681C1524A4 for <opsawg@ietf.org>; Mon, 17 Oct 2022 04:01:42 -0700 (PDT)
Received: from opfedar00.francetelecom.fr (unknown [xx.xx.xx.11]) (using TLSv1.3 with cipher TLS_AES_256_GCM_SHA384 (256/256 bits) key-exchange X25519 server-signature RSA-PSS (2048 bits)) (No client certificate requested) by opfedar26.francetelecom.fr (ESMTP service) with ESMTPS id 4MrYw43QQ8zFq9j; Mon, 17 Oct 2022 13:01:40 +0200 (CEST)
DKIM-Signature: v=1; a=rsa-sha256; c=relaxed/relaxed; d=orange.com; s=ORANGE001; t=1666004500; bh=AFYlBvT/V7fMuQEozosYjpavDI/iwQZxMVfvdRUm1dE=; h=From:To:Subject:Date:Message-ID:Content-Type:MIME-Version; b=u1jK7Dx22HJBj8TLwI8Djre632VbxZniL73Uyl+MboYYA3qpKy4MCbe9u8BJVG/xm PUamlLKxKnXkukmXd0pRjm3f7rhge+ANncxEiMO6D71mcChUDURr63vqPjwyptqJos C9HgFjacRG6D+6CFjbw8/CK6xNWTKqtiFthc4Tm/GeYnkNNl9wN5MwolIpGUW47732 h2VSq99llyubG/pgTugQEUl5M7YUbSwV+RRKdcktvEaphtOFzEDBbALVIlMrVpe/p0 dn0NwVqnU4mJ3Zzge99rUMwa1FbCi8WPDRS81VMb1CeUOzZVIgxYlEPcVkFrjUvJP1 JRKoeN3bvs5lA==
From: mohamed.boucadair@orange.com
To: Thomas Fossati <Thomas.Fossati@arm.com>, opsawg <opsawg@ietf.org>
Thread-Topic: draft-ietf-opsawg-mud-tls YANG Doctor review
Thread-Index: AQHY4g3KLTlHJPvslUqBCOB9oi6noq4Sajbw
Content-Class:
Date: Mon, 17 Oct 2022 11:01:40 +0000
Message-ID: <5665_1666004500_634D3614_5665_438_1_28a4eb12b88a4ad6b157cf610d24f976@orange.com>
References: <DB9PR08MB6524DDF4D7F4ACCECD85469C9C299@DB9PR08MB6524.eurprd08.prod.outlook.com>
In-Reply-To: <DB9PR08MB6524DDF4D7F4ACCECD85469C9C299@DB9PR08MB6524.eurprd08.prod.outlook.com>
Accept-Language: fr-FR, en-US
Content-Language: fr-FR
X-MS-Has-Attach:
X-MS-TNEF-Correlator:
msip_labels: MSIP_Label_07222825-62ea-40f3-96b5-5375c07996e2_Enabled=true; MSIP_Label_07222825-62ea-40f3-96b5-5375c07996e2_SetDate=2022-10-17T10:56:57Z; MSIP_Label_07222825-62ea-40f3-96b5-5375c07996e2_Method=Privileged; MSIP_Label_07222825-62ea-40f3-96b5-5375c07996e2_Name=unrestricted_parent.2; MSIP_Label_07222825-62ea-40f3-96b5-5375c07996e2_SiteId=90c7a20a-f34b-40bf-bc48-b9253b6f5d20; MSIP_Label_07222825-62ea-40f3-96b5-5375c07996e2_ActionId=96a7aabd-bbad-4eb8-99ce-7dc0c5e3e28d; MSIP_Label_07222825-62ea-40f3-96b5-5375c07996e2_ContentBits=0
x-originating-ip: [10.115.26.50]
Content-Type: multipart/alternative; boundary="_000_28a4eb12b88a4ad6b157cf610d24f976orangecom_"
MIME-Version: 1.0
Archived-At: <https://mailarchive.ietf.org/arch/msg/opsawg/ruvVnJFa2YLPMXRIKqf5rGaDPN4>
Subject: Re: [OPSAWG] draft-ietf-opsawg-mud-tls YANG Doctor review
X-BeenThere: opsawg@ietf.org
X-Mailman-Version: 2.1.39
Precedence: list
List-Id: OPSA Working Group Mail List <opsawg.ietf.org>
List-Unsubscribe: <https://www.ietf.org/mailman/options/opsawg>, <mailto:opsawg-request@ietf.org?subject=unsubscribe>
List-Archive: <https://mailarchive.ietf.org/arch/browse/opsawg/>
List-Post: <mailto:opsawg@ietf.org>
List-Help: <mailto:opsawg-request@ietf.org?subject=help>
List-Subscribe: <https://www.ietf.org/mailman/listinfo/opsawg>, <mailto:opsawg-request@ietf.org?subject=subscribe>
X-List-Received-Date: Mon, 17 Oct 2022 11:01:46 -0000

Hi Thomas,

I don't see why this draft should be an exception.

BTW in addition to the yang doctors review, I suggest to also request an early secdir review. Thanks.

Cheers,
Med

De : OPSAWG <opsawg-bounces@ietf.org> De la part de Thomas Fossati
Envoyé : lundi 17 octobre 2022 12:10
À : opsawg <opsawg@ietf.org>
Objet : [OPSAWG] draft-ietf-opsawg-mud-tls YANG Doctor review

Hi, all,

I was asked to bring to the list one comment from my shepherd write-up
[1]; specifically, that draft-ietf-opsawg-mud-tls hasn't been reviewed
by the YANG Doctors (yet).

There seems to be an expectation [2] that the YANG Doctor review is
completed before or during WGLC.

I am not sure whether the expectation is still current, or needs to be
relaxed for some reasons.  This is also of interest to me because I am
new to the shepherding process and I'd like to understand what are the
(best) current practices in the YANG area.

Cheers, thanks.
t

[1] https://datatracker.ietf.org/doc/draft-ietf-opsawg-mud-tls/shepherdwriteup/
[2] https://trac.ietf.org/trac/ops/wiki/yang-doctors-review#Purpose

--

IMPORTANT NOTICE: The contents of this email and any attachments are confidential and may also be privileged. If you are not the intended recipient, please notify the sender immediately and do not disclose the contents to any other person, use it for any purpose, or store or copy the information in any medium. Thank you.

_________________________________________________________________________________________________________________________

Ce message et ses pieces jointes peuvent contenir des informations confidentielles ou privilegiees et ne doivent donc
pas etre diffuses, exploites ou copies sans autorisation. Si vous avez recu ce message par erreur, veuillez le signaler
a l'expediteur et le detruire ainsi que les pieces jointes. Les messages electroniques etant susceptibles d'alteration,
Orange decline toute responsabilite si ce message a ete altere, deforme ou falsifie. Merci.

This message and its attachments may contain confidential or privileged information that may be protected by law;
they should not be distributed, used or copied without authorisation.
If you have received this email in error, please notify the sender and delete this message and its attachments.
As emails may be altered, Orange is not liable for messages that have been modified, changed or falsified.
Thank you.